Literature DB >> 35720641

Epigenome editing and epigenetic gene regulation in disease phenotypes.

Gaochen Jin1, Bomyi Lim1.   

Abstract

Proper gene control across space and time is crucial for the seamless execution of various cellular functions. Rapid advancements in genome-wide studies revealed that in addition to genetic mutations, epigenetic modifications also play an important role in cellular processes and disease development. Epigenetic modifications, including DNA methylation and post-translational modifications on histones via methylation, acetylation, phosphorylation, etc., do not alter DNA sequences. Yet, disruptions of the epigenome can still induce gene malfunction, aberrant cell differentiation, proliferation, and apoptosis, resulting in various diseases such as cancer, neurological disorders, and autoimmune diseases. This review describes the association between epigenetic modifications and disease phenotypes, current techniques to perturb epigenome and analyze changes in gene expression, and perspectives on future epigenetic research.

Entities:  

Keywords:  CRISPR-dCas9; DNA methylation; Epigenetics; Gene regulation; Histone modification

Year:  2022        PMID: 35720641      PMCID: PMC9202778          DOI: 10.1007/s11814-022-1076-5

Source DB:  PubMed          Journal:  Korean J Chem Eng        ISSN: 0256-1115            Impact factor:   3.146


  66 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  The nuclear to cytoplasmic ratio directly regulates zygotic transcription in Drosophila through multiple modalities.

Authors:  Sahla Syed; Henry Wilky; João Raimundo; Bomyi Lim; Amanda A Amodeo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 3.  Epigenetic drivers of tumourigenesis and cancer metastasis.

Authors:  Aniruddha Chatterjee; Euan J Rodger; Michael R Eccles
Journal:  Semin Cancer Biol       Date:  2017-08-12       Impact factor: 15.707

4.  Complex transcriptional modulation with orthogonal and inducible dCas9 regulators.

Authors:  Yuchen Gao; Xin Xiong; Spencer Wong; Emeric J Charles; Wendell A Lim; Lei S Qi
Journal:  Nat Methods       Date:  2016-10-24       Impact factor: 28.547

5.  Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9.

Authors:  Daniel M Sapozhnikov; Moshe Szyf
Journal:  Nat Commun       Date:  2021-09-29       Impact factor: 17.694

6.  Localization of ASH1 mRNA particles in living yeast.

Authors:  E Bertrand; P Chartrand; M Schaefer; S M Shenoy; R H Singer; R M Long
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

7.  Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts.

Authors:  Takuma Tsuzuki Wada; Yasuto Araki; Kojiro Sato; Yoshimi Aizaki; Kazuhiro Yokota; Yoon Taek Kim; Hiromi Oda; Riki Kurokawa; Toshihide Mimura
Journal:  Biochem Biophys Res Commun       Date:  2014-02-07       Impact factor: 3.575

8.  Live-cell imaging reveals enhancer-dependent Sox2 transcription in the absence of enhancer proximity.

Authors:  Jeffrey M Alexander; Juan Guan; Bingkun Li; Lenka Maliskova; Michael Song; Yin Shen; Bo Huang; Stavros Lomvardas; Orion D Weiner
Journal:  Elife       Date:  2019-05-24       Impact factor: 8.140

9.  Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase.

Authors:  Peter Stepper; Goran Kungulovski; Renata Z Jurkowska; Tamir Chandra; Felix Krueger; Richard Reinhardt; Wolf Reik; Albert Jeltsch; Tomasz P Jurkowski
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

10.  DNMT Inhibitors Increase Methylation in the Cancer Genome.

Authors:  Anil K Giri; Tero Aittokallio
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.